Media Room

Welcome to our Media Room.

This page is intended for media-related inquiries and we will be happy to assist and provide current and historical news as well as new developments.

Latest News

Contact

	Jerusalem, Israel, July 1, 2009 Teva Announces Approval and Launch of Tri-Lo Sprintec Tablets
	Jerusalem, Israel and Ewing, New Jersey, June 30, 2009 Teva and Antares Announce FDA Approval of Needle-Free Injector Product for Administration of Tev-Tropin® (Human Growth Hormone)

Ayala Miller

Director, Corporate Communications
Teva Pharmaceutical Industries Ltd.

Denise Bradley

Director, Communications & Community
Relations
Teva North America.

	Tel: +1-215-5918974
	denise.bradley@tevausa.com